Found: 25 articles

Article Edition
V.V. Fomin. L.V. Kozlovskaya, Yu.S. Milovanov
Cardiomyopathy in anemia, associated with chronic kidney disease: role of erythropoetin-beta
№6 / 2011
L.V. Kozlovskaya, Yu.S. Milovanova, L.Yu. Milovanova
Optimal target hemoglobin level in chronic kidney disease patients, treated with erythropoesis-stimulating agents: controversial questions
№5 / 2011
V.V. Fomin, L.V. Kozlovskaya, Yu.S. Milovanov, L.Yu. Milovanova
Cardio-renal anemia syndrome: correction with iron sucrose
№4 / 2011
V.Yu. Shilo, A.Yu. Denisov
Treatment of anemia in chronic kidney disease: the present, the past and the future
№3 / 2011
P.A. Vorobyev, L.Yu. Bezmenitsina
Epidemiology and quality of life in patients with chronic renal failire and anemia, receiving programm hemodyalisis. Part 2. Quality of life and costs of erythropoietin treatment
№2 / 2011
Yu.S. Milovanov, L.Yu. Milovanov, L.V. Kozlovskaya
Use of trihydric iron preparations in treatment of anemia in patients with pre-dialysis renal failure
№2 / 2011
E.V. Shutov, S.V. Lashutin, I.G. Kolomiitseva, E.V. Shuvalov
Treatment of anemia with methoxypolyethyleneglycol – epoetin beta in patients on haemodyalisis
№2 / 2011
P.A. Vorobev, L.J. Bezmelnitsyna
Epidemiology and quality of life in patients with chronic renal failire and anemia, receiving programm hemodyalisis. Part 1. Epidemiology and use of erythropoietin medications
№1 / 2011
J.S. Milovanov, L.J. Milovanova, L.V. Kozlovskaya
Anaemia in chronic kidney disease: pathogenesis, prognostic sighnificance, treatment
№6 / 2010
M.A. Shestakova, S.A. Martynov
Anaemia correction in diabetic nephropathy: target haemoglobin values and cardiovascular complications
№5 / 2010
L.V. Kozlovskaya, Yu.S. Milovanov, L.Yu. Milovanova, I.A. Dobrosmislov
Difficulties in renal anemia treatment. Role of prolonged erythropoietin receptor activator
№2 / 2010
R.R. Kaliev, A.B. Budaichieva, I.T. Murkamilov
Renal anemia influence on kidney function and survival of patients with chronic glomerulonephritis
№1 / 2010


Бионика Медиа